JP2009298801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009298801A5 JP2009298801A5 JP2009187938A JP2009187938A JP2009298801A5 JP 2009298801 A5 JP2009298801 A5 JP 2009298801A5 JP 2009187938 A JP2009187938 A JP 2009187938A JP 2009187938 A JP2009187938 A JP 2009187938A JP 2009298801 A5 JP2009298801 A5 JP 2009298801A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- acceptable salt
- pharmaceutically acceptable
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241000283898 Ovis Species 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 241000555745 Sciuridae Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 241000282458 Ursus sp. Species 0.000 claims 1
- 230000001154 acute Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- HZOVBXHLEVMAML-FIMAOPCTSA-N CCN(CC)Cc(cc1)c(C[C@@H](C[C@@H]([C@H](C(O)=C(C(N)=O)C2=O)N(C)C)[C@@]22O)C(C3=O)=C2O)c3c1O Chemical compound CCN(CC)Cc(cc1)c(C[C@@H](C[C@@H]([C@H](C(O)=C(C(N)=O)C2=O)N(C)C)[C@@]22O)C(C3=O)=C2O)c3c1O HZOVBXHLEVMAML-FIMAOPCTSA-N 0.000 description 1
- 0 CCN(CC)Cc1ccc(*)c(C(C2=C([C@@]([C@@](C3)C(C(O)=C4C(*)=*)N(C)C)(C4=O)O)O)=O)c1C[C@]23[U] Chemical compound CCN(CC)Cc1ccc(*)c(C(C2=C([C@@]([C@@](C3)C(C(O)=C4C(*)=*)N(C)C)(C4=O)O)O)=O)c1C[C@]23[U] 0.000 description 1
Claims (7)
- 請求項1または2に記載の化合物、またはその薬学的に許容される塩を含む、哺乳類における急性または慢性の感染を治療するための薬学的組成物。
- 前記哺乳類が、ネコ、イヌ、ウマ、ブタ、ウシ、ヒツジ、齧歯類、ウサギ、リス、およびクマからなる群から選択される、請求項3記載の薬学的組成物。
- 前記化合物が、第二の薬剤と組み合わせて投与されるように用いられる、請求項3または4記載の薬学的組成物。
- 前記第二の薬剤が、抗感染剤である、請求項5記載の薬学的組成物。
- 担体と組み合わせて、請求項1または2記載の化合物、またはその薬学的に許容される塩の有効な量を含む、薬学的組成物。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30554601P | 2001-07-13 | 2001-07-13 | |
US60/305,546 | 2001-07-13 | ||
US39574102P | 2002-07-12 | 2002-07-12 | |
US60/395,741 | 2002-07-12 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003511780A Division JP2004537544A (ja) | 2001-07-13 | 2002-07-15 | 標的治療活性を有するテトラサイクリン化合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009298801A JP2009298801A (ja) | 2009-12-24 |
JP2009298801A5 true JP2009298801A5 (ja) | 2012-06-21 |
JP5182956B2 JP5182956B2 (ja) | 2013-04-17 |
Family
ID=29553007
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003511780A Pending JP2004537544A (ja) | 2001-07-13 | 2002-07-15 | 標的治療活性を有するテトラサイクリン化合物 |
JP2009187938A Expired - Fee Related JP5182956B2 (ja) | 2001-07-13 | 2009-08-14 | 標的治療活性を有するテトラサイクリン化合物 |
JP2010256651A Pending JP2011057693A (ja) | 2001-07-13 | 2010-11-17 | 標的治療活性を有するテトラサイクリン化合物 |
JP2010256652A Pending JP2011057694A (ja) | 2001-07-13 | 2010-11-17 | 標的治療活性を有するテトラサイクリン化合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003511780A Pending JP2004537544A (ja) | 2001-07-13 | 2002-07-15 | 標的治療活性を有するテトラサイクリン化合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010256651A Pending JP2011057693A (ja) | 2001-07-13 | 2010-11-17 | 標的治療活性を有するテトラサイクリン化合物 |
JP2010256652A Pending JP2011057694A (ja) | 2001-07-13 | 2010-11-17 | 標的治療活性を有するテトラサイクリン化合物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040063674A1 (ja) |
EP (11) | EP2332546A1 (ja) |
JP (4) | JP2004537544A (ja) |
AU (1) | AU2002318238A1 (ja) |
WO (1) | WO2003005971A2 (ja) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60027465T2 (de) * | 1999-09-14 | 2007-02-01 | The Trustees Of Tufts College, Medford | Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemien |
US8106225B2 (en) * | 1999-09-14 | 2012-01-31 | Trustees Of Tufts College | Methods of preparing substituted tetracyclines with transition metal-based chemistries |
WO2001052858A1 (en) * | 2000-01-24 | 2001-07-26 | Trustees Of Tufts College | Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
MXPA02009482A (es) * | 2000-03-31 | 2004-05-14 | Tufts College | Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino. |
AU2001259701A1 (en) * | 2000-05-15 | 2001-11-26 | Paratek Pharmaceuticals, Inc | 7-substituted fused ring tetracycline compounds |
AU2001268475A1 (en) * | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
US7094806B2 (en) | 2000-07-07 | 2006-08-22 | Trustees Of Tufts College | 7, 8 and 9-substituted tetracycline compounds |
US6846939B2 (en) | 2000-07-07 | 2005-01-25 | Paratek Pharmaceuticals, Inc. | 9-substituted minocycline compounds |
US7553828B2 (en) * | 2001-03-13 | 2009-06-30 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl substituted minocycline compounds |
WO2002072506A2 (en) * | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7-pyrollyl tetracycline compounds and methods of use thereof |
BR0116935A (pt) * | 2001-03-13 | 2005-04-12 | Paratek Pharm Innc | Composto de tetraciclina, método para tratar um estado responsivo à tetraciclina em um indivìduo, e, composição farmacêutica |
WO2002072031A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as synergistic antifungal agents |
US8088820B2 (en) * | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
AU2002310409C1 (en) * | 2001-06-11 | 2008-04-17 | Xenoport, Inc. | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
EP2332546A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
AU2002365120A1 (en) | 2001-08-02 | 2003-07-15 | Paratek Pharmaceuticals, Inc. | Medicaments |
EP1894569A3 (en) * | 2001-10-05 | 2008-05-07 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives for treating cancer |
EP2311796A1 (en) * | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
AU2003220123B2 (en) * | 2002-03-08 | 2009-05-07 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
WO2003079984A2 (en) | 2002-03-21 | 2003-10-02 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
US20050164993A1 (en) * | 2002-05-20 | 2005-07-28 | Ashley Robert A. | Methods of treating allergic reactions |
AU2003256496A1 (en) * | 2002-07-12 | 2004-02-02 | The Research Foundation Of State University Of New York | Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations |
WO2004006850A2 (en) * | 2002-07-12 | 2004-01-22 | Paratek Pharmaceuticals, Inc | 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
US20060128675A1 (en) * | 2002-08-09 | 2006-06-15 | Durkin Helen G | Method for monitoring the effectiveness of teracycline in the treatment of asthma |
EP2277504A1 (en) * | 2002-10-24 | 2011-01-26 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
US8173624B2 (en) * | 2002-10-24 | 2012-05-08 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate RNA |
DK1615622T3 (da) * | 2003-04-07 | 2012-10-15 | Supernus Pharmaceuticals Inc | Doxycyclinpræparater til indgivelse én gang dagligt |
CN101786991A (zh) | 2003-07-09 | 2010-07-28 | 帕拉特克药品公司 | 取代的四环素化合物 |
US20060287283A1 (en) * | 2003-07-09 | 2006-12-21 | Paratek Pharmaceuticals, Inc. | Prodrugs of 9-aminomethyl tetracycline compounds |
JP4738333B2 (ja) * | 2003-07-09 | 2011-08-03 | パラテック ファーマシューティカルズ インコーポレイテッド | 9−アミノメチルテトラサイクリン化合物のプロドラッグ |
CN1893956A (zh) * | 2003-07-25 | 2007-01-10 | 沃纳奇尔科特公司 | 多西环素金属络合物固体剂型 |
US20050148553A1 (en) * | 2003-09-05 | 2005-07-07 | Testa Raymond T. | Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
UA83266C2 (en) * | 2003-12-08 | 2008-06-25 | Уайет | Oxazole derivatives of tetracyclines |
JP5010284B2 (ja) | 2004-01-15 | 2012-08-29 | パラテック ファーマシューティカルズ インコーポレイテッド | テトラサイクリン化合物の芳香族a環誘導体 |
ES2607453T3 (es) | 2004-05-21 | 2017-03-31 | President And Fellows Of Harvard College | Síntesis de tetraciclinas y sus análogos |
US20050288379A1 (en) * | 2004-06-21 | 2005-12-29 | Xiaoqiang Yan | Benzoquinone compounds as anti-cancer agents |
TWI261038B (en) * | 2004-08-11 | 2006-09-01 | Bo-Cheng Chen | Bicycle gear-shifting handgrip |
AU2005299294B2 (en) | 2004-10-25 | 2012-06-07 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
EP2284150A3 (en) * | 2004-10-25 | 2011-09-21 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
EP1811986B1 (en) | 2004-11-04 | 2014-03-26 | XenoPort, Inc. | Gabapentin prodrug sustained release oral dosage forms |
US8088755B2 (en) | 2005-02-04 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | 11a, 12-derivatives of tetracycline compounds |
JP2008530123A (ja) * | 2005-02-09 | 2008-08-07 | ジェネンテック・インコーポレーテッド | マトリックスメタロプロテアーゼアンタゴニストを用いたher2のシェディングの阻害 |
PE20061107A1 (es) | 2005-03-14 | 2006-12-08 | Wyeth Corp | Composiciones de tigeciclina y metodos para su preparacion |
US8211874B2 (en) * | 2005-06-03 | 2012-07-03 | Galderma Laboratories Inc. | Inhibition of thrombin generation |
WO2007014154A2 (en) * | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
WO2007075792A1 (en) * | 2005-12-22 | 2007-07-05 | Wyeth | Methods of treating gastrointestinal tract infections with tigecycline |
EP1965770A2 (en) * | 2005-12-22 | 2008-09-10 | Wyeth a Corporation of the State of Delaware | Oral formulations comprising tigecycline |
US20080027031A1 (en) * | 2006-03-08 | 2008-01-31 | Kinemed, Inc. | Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders |
EP2016044B1 (en) * | 2006-04-07 | 2020-06-10 | President and Fellows of Harvard College | Pentacycline derivatives for the treatment of infections |
WO2007127908A2 (en) * | 2006-04-28 | 2007-11-08 | Hutchison Medipharma Enterprises Limited | Dihydrobenzoquinone compounds |
EP3056487B1 (en) * | 2006-10-11 | 2018-02-21 | President and Fellows of Harvard College | Synthesis of enone intermediate |
US8440646B1 (en) | 2006-10-11 | 2013-05-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of Bacillus anthracis infections |
WO2008047340A1 (en) * | 2006-10-19 | 2008-04-24 | Mor Research Applications Ltd. | Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
PT2120963T (pt) | 2006-12-21 | 2018-12-17 | Paratek Pharm Innc | Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele |
ES2463457T3 (es) | 2006-12-21 | 2014-05-28 | Paratek Pharmaceuticals, Inc. | Derivados de la tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias |
JP2010520210A (ja) * | 2007-02-28 | 2010-06-10 | アーシエックス セラピューティックス, インコーポレイテッド | マイボーム腺分泌を正常化するための方法および組成物 |
EP2144614A1 (en) | 2007-04-12 | 2010-01-20 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
ES2388958T3 (es) | 2007-11-29 | 2012-10-22 | Actelion Pharmaceuticals Ltd. | Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12 |
WO2009111064A2 (en) | 2008-03-05 | 2009-09-11 | Paratek Pharmaceuticals, Inc. | Minocycline compounds and methods of use thereof |
PT2271348T (pt) * | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Formulação de comprimido oral de composto de tetraciclina |
JP2011527708A (ja) | 2008-07-11 | 2011-11-04 | ニュメディックス | 減少した抗菌活性および神経保護作用の利点を有するテトラサイクリン誘導体 |
RS54485B1 (en) | 2008-08-08 | 2016-06-30 | Tetraphase Pharmaceuticals, Inc. | C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS |
AP2011005631A0 (en) * | 2008-09-19 | 2011-04-30 | Paratek Pharmaceuticals Ind | Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment. |
WO2010126607A2 (en) | 2009-04-30 | 2010-11-04 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
US9315451B2 (en) | 2009-05-08 | 2016-04-19 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
DK2470500T3 (en) | 2009-08-28 | 2018-01-08 | Tetraphase Pharmaceuticals Inc | tetracycline |
US9327015B2 (en) * | 2009-10-23 | 2016-05-03 | DePuy Synthes Products, Inc. | Methods and devices for correcting spinal deformity with pharmaceutical-eluting pedicle screws |
CN101967108B (zh) * | 2010-09-13 | 2013-06-19 | 苏春华 | 一种美他环素的衍生物 |
EP2643021A4 (en) * | 2010-11-23 | 2014-11-05 | Fpinnovations | BONDING AGENT WITH NANOCRYSTALLINE CELLULOSE (NCC) |
WO2013181391A2 (en) * | 2012-05-30 | 2013-12-05 | Paratek Pharmaceuticals, Inc. | 7-disubstituted-phenyl tetracycline derivatives |
CA2883238C (en) | 2012-08-31 | 2021-11-23 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
WO2014200213A1 (ko) * | 2013-06-13 | 2014-12-18 | 한국생명공학연구원 | 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물 |
KR101660815B1 (ko) * | 2013-06-13 | 2016-09-29 | 한국생명공학연구원 | 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물 |
KR101750834B1 (ko) | 2014-10-07 | 2017-06-26 | 연세대학교 산학협력단 | 알파-시누클레인 응집체의 파괴에 의하여 파킨슨 질환을 치료 또는 예방하기 위한 조성물 |
BR112018069303A2 (pt) * | 2016-03-24 | 2019-01-22 | Paratek Pharm Innc | método para tratamento de uma infecção |
WO2018005527A1 (en) * | 2016-06-27 | 2018-01-04 | Ohio State Innovation Foundation | Liponucleotide-based therapy for ards |
CN110582486B (zh) | 2016-10-19 | 2024-01-12 | 四相制药公司 | 艾若威四环素的结晶形式 |
SG10201913599RA (en) | 2016-11-01 | 2020-02-27 | Paratek Pharm Innc | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp) |
CA3234239A1 (en) | 2018-06-13 | 2019-12-19 | Texas Tech University System | Modified tetracycline for treatment of alcohol use disorder, pain and other disorders involving potential inflammatory processes |
US20220175803A1 (en) * | 2019-04-04 | 2022-06-09 | Cmtx Biotech Inc. | Methods of treating charcot-marie-tooth disease |
EP3990440A4 (en) * | 2019-06-28 | 2022-09-07 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR THE TREATMENT OF DISEASES OF THE NEUROMYELITIS OPTICA SPECTRUM |
EP4133047A1 (en) | 2020-04-10 | 2023-02-15 | The Procter & Gamble Company | Cleaning article with preferential rheological solid composition |
EP4229161A1 (en) | 2020-10-16 | 2023-08-23 | The Procter & Gamble Company | Cleaning article with preferential coating |
WO2024075662A1 (ja) * | 2022-10-03 | 2024-04-11 | 国立研究開発法人国立循環器病研究センター | 脳卒中の検査方法、及び脳卒中の改善剤 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862225A (en) | 1961-08-18 | 1975-01-21 | Pfizer | D-ring substituted tetracyclines |
US3326761A (en) * | 1964-11-16 | 1967-06-20 | Pfizer & Co C | 6-demethyl-6-deoxytetracycline, anti-tumor antibiotic |
US3304227A (en) | 1965-07-15 | 1967-02-14 | Loyal E Loveless | Antibiotic-containing animal feed |
US4066694A (en) | 1971-02-09 | 1978-01-03 | Pfizer Inc. | 4-hydroxy-4-dedimethylamino-tetracyclines |
US3622627A (en) | 1967-09-13 | 1971-11-23 | Pfizer | 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof |
US4806529A (en) | 1982-11-18 | 1989-02-21 | Trustees Of Tufts College, Tufts University | Tetracycline activity enhancement |
US4666897A (en) | 1983-12-29 | 1987-05-19 | Research Foundation Of State University | Inhibition of mammalian collagenolytic enzymes by tetracyclines |
US4925833A (en) | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
USRE34656E (en) | 1983-12-29 | 1994-07-05 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency |
US4935412A (en) | 1983-12-29 | 1990-06-19 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
US4704383A (en) | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
US5308839A (en) | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
JP3016587B2 (ja) | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
FR2660193B1 (fr) | 1990-04-03 | 1994-11-04 | Philippe Maincent | Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules. |
US5770588A (en) | 1991-02-11 | 1998-06-23 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions of the prevention and treatment of root caries |
DE69117057T2 (de) | 1991-03-22 | 1996-08-29 | William S Carson | Behälter mit einer greiferanordnung für das sammeln von wiedertverwertbaren materialien |
US5231017A (en) | 1991-05-17 | 1993-07-27 | Solvay Enzymes, Inc. | Process for producing ethanol |
US5281628A (en) | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
ES2168254T3 (es) | 1991-10-04 | 2002-06-16 | American Cyanamid Co | Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas. |
US5494903A (en) | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
US5258371A (en) | 1992-05-29 | 1993-11-02 | Kuraray Co., Ltd. | Method to reduce connective tissue destruction |
US6043225A (en) | 1992-06-12 | 2000-03-28 | Board Of Regents Of The University Of Washington | Diagnosis and treatment of arterial chlamydial granuloma |
US5442059A (en) | 1992-08-13 | 1995-08-15 | American Cyanamid Company | 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines |
US5284963A (en) | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
SG47520A1 (en) | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
US5328902A (en) | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
US5420272A (en) | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
DE4227616C2 (de) | 1992-08-20 | 1995-04-13 | Sigma Tau Ind Farmaceuti | 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen |
US5362754A (en) * | 1992-11-12 | 1994-11-08 | Univ. Of Tx Md Anderson Cancer Center | M-EDTA pharmaceutical preparations and uses thereof |
US5688516A (en) * | 1992-11-12 | 1997-11-18 | Board Of Regents, The University Of Texas System | Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices |
CA2103189C (en) | 1992-11-17 | 2005-05-03 | Lorne M. Golub | Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
US5523297A (en) | 1993-03-02 | 1996-06-04 | The Research Foundation Of State University Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
US6043231A (en) | 1993-03-02 | 2000-03-28 | The Research Foundation Of State Univ. Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
US5371076A (en) | 1993-04-02 | 1994-12-06 | American Cyanamid Company | 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
US5668122A (en) | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
EP0745065A1 (en) | 1994-02-17 | 1996-12-04 | Pfizer Inc. | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
US5698533A (en) | 1994-07-26 | 1997-12-16 | Kang; Meng-Che | Ophthalmic pharmaceutical composition |
US5530557A (en) | 1994-09-12 | 1996-06-25 | International Business Machines Corporation | Online placement of video files determined by a function of the bandwidth to space ratio of each of the storage devices in a server environment |
US5843925A (en) | 1994-12-13 | 1998-12-01 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US5574026A (en) | 1994-12-13 | 1996-11-12 | American Cyanamid Company | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth |
EP0733369A1 (en) * | 1995-03-23 | 1996-09-25 | Stichting REGA V.Z.W. | Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
EP0736302A3 (en) * | 1995-03-23 | 1997-06-04 | Stichting Rega V Z W | Protease inhibitors, DNA construction for protease expression and a method for measuring proteases and / or protease inhibitors |
CA2219277A1 (en) | 1995-05-03 | 1996-11-07 | Pfizer Limited | Novel tetracycline derivatives |
US5834449A (en) | 1996-06-13 | 1998-11-10 | The Research Foundation Of State University Of New York | Treatment of aortic and vascular aneurysms with tetracycline compounds |
US5827840A (en) | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
US5837696A (en) | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
US5773430A (en) * | 1997-03-13 | 1998-06-30 | Research Foundation Of State University Of New York | Serine proteinase inhibitory activity by hydrophobic tetracycline |
US5929055A (en) | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
WO1999009997A1 (en) * | 1997-08-26 | 1999-03-04 | Board Of Regents, The University Of Texas System | Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
ATE399013T1 (de) | 1997-12-19 | 2008-07-15 | Univ New York | Nicht antibakterielle tetracycline zur behandlung der multiplen sklerose |
JP2001527040A (ja) * | 1997-12-30 | 2001-12-25 | バイオアブソーバブル コンセプツ,インコーポレイティド | 神経系の脳血管性疾患を治療、抑制及び防止するためのテトラサイクリン及び/又はテトラサイクリン誘導体 |
US7189703B2 (en) | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
CA2318580A1 (en) * | 1998-01-23 | 1999-07-29 | Mark L. Nelson | Pharmaceutically active compounds and methods of use thereof |
US6277061B1 (en) | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
US6455583B1 (en) * | 1998-05-08 | 2002-09-24 | The University Of Miami | Method for treating meibomian gland disease |
US6015804A (en) | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5977091A (en) | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
SE9803710L (sv) * | 1998-09-25 | 2000-03-26 | A & Science Invest Ab | Användning av vissa substanser för behandling av nervrotsskador |
US5998390A (en) | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
US6506740B1 (en) | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
AU766200B2 (en) | 1998-11-18 | 2003-10-09 | Collagenex Pharmaceuticals, Inc. | Novel 4-dedimethy laminotetra cycline derivatives |
WO2000057187A2 (en) * | 1999-03-19 | 2000-09-28 | Vanderbilt University | Diagnosis and treatment of multiple sclerosis |
EP1171163A1 (en) * | 1999-04-27 | 2002-01-16 | Antibody Systems, Inc. | Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
DE60027465T2 (de) | 1999-09-14 | 2007-02-01 | The Trustees Of Tufts College, Medford | Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemien |
US6231894B1 (en) | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
KR20010069066A (ko) * | 2000-01-12 | 2001-07-23 | 이종원 | 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법 |
WO2001052858A1 (en) | 2000-01-24 | 2001-07-26 | Trustees Of Tufts College | Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
MXPA02009482A (es) | 2000-03-31 | 2004-05-14 | Tufts College | Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino. |
US7235397B1 (en) * | 2000-04-14 | 2007-06-26 | Gensys, Inc. | Methods and compositions for culturing spirochete and treating spirochetal diseases |
US6613756B2 (en) | 2000-05-05 | 2003-09-02 | Wisconsin Alumni Research Foundation | Use of tetracycline derivatives in treating multiple sclerosis |
AU2001259701A1 (en) | 2000-05-15 | 2001-11-26 | Paratek Pharmaceuticals, Inc | 7-substituted fused ring tetracycline compounds |
AU2001268475A1 (en) | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
WO2001098260A1 (en) | 2000-06-16 | 2001-12-27 | Trustees Of Tufts College | 7-n-substituted phenyl tetracycline compounds |
AU2000254942A1 (en) | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
CA2415718C (en) | 2000-07-07 | 2012-08-28 | Trustees Of Tufts College | 7-substituted tetracycline compounds |
WO2002004404A2 (en) | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 7,8 and 9-substituted tetracycline compounds |
WO2002012170A1 (en) | 2000-08-04 | 2002-02-14 | Trustees Of Tufts College | 8-substituted tetracycline compounds |
US6846939B2 (en) * | 2000-07-07 | 2005-01-25 | Paratek Pharmaceuticals, Inc. | 9-substituted minocycline compounds |
AU2001288792A1 (en) | 2000-09-06 | 2002-03-22 | Neurotherapeutics, Llc | Method of treating neurologic disorders |
US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
WO2002072031A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as synergistic antifungal agents |
US6841546B2 (en) * | 2001-03-14 | 2005-01-11 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
ATE455092T1 (de) * | 2001-04-24 | 2010-01-15 | Paratek Pharm Innc | Substituierte tetracyclin-verbindungen zur behandlung von malaria |
EP2332546A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
CN1615152A (zh) * | 2001-12-07 | 2005-05-11 | 强生消费者公司 | 减少痤疮或改善皮色的方法 |
EP2311796A1 (en) * | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
US20030186946A1 (en) * | 2002-01-29 | 2003-10-02 | Cooper Garth James Smith | Suppression of cytotoxic protein conformers |
AU2003220123B2 (en) * | 2002-03-08 | 2009-05-07 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
DE10228326A1 (de) * | 2002-06-25 | 2004-01-22 | Heribert Dr.med. Bohlen | Verwendung von Macrolid- und/oder Tetracyclin-Verbindungen und/oder Gyrasehemmer enthaltenden Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen |
JP5706185B2 (ja) | 2011-02-22 | 2015-04-22 | 富士レビオ株式会社 | 測定装置及び測定方法 |
US9713502B2 (en) | 2014-03-09 | 2017-07-25 | Gyrus Acmi, Inc. | Narrow band imaging with surgical loupes |
-
2002
- 2002-07-15 EP EP10185605A patent/EP2332546A1/en not_active Withdrawn
- 2002-07-15 AU AU2002318238A patent/AU2002318238A1/en not_active Abandoned
- 2002-07-15 EP EP10185627A patent/EP2327409A1/en not_active Withdrawn
- 2002-07-15 EP EP02748169.6A patent/EP1408987B1/en not_active Expired - Lifetime
- 2002-07-15 WO PCT/US2002/022451 patent/WO2003005971A2/en active Search and Examination
- 2002-07-15 JP JP2003511780A patent/JP2004537544A/ja active Pending
- 2002-07-15 EP EP10185596A patent/EP2301550A1/en not_active Withdrawn
- 2002-07-15 EP EP10185600A patent/EP2301915A1/en not_active Withdrawn
- 2002-07-15 EP EP10185619A patent/EP2329828A1/en not_active Withdrawn
- 2002-07-15 US US10/196,010 patent/US20040063674A1/en not_active Abandoned
- 2002-07-15 EP EP10185614A patent/EP2332547A1/en not_active Withdrawn
- 2002-07-15 EP EP10185677A patent/EP2332550A1/en not_active Withdrawn
- 2002-07-15 EP EP10185610A patent/EP2329826A1/en not_active Withdrawn
- 2002-07-15 EP EP10185623A patent/EP2332548A1/en not_active Withdrawn
- 2002-07-15 EP EP10185666A patent/EP2332549A1/en not_active Withdrawn
-
2009
- 2009-08-14 JP JP2009187938A patent/JP5182956B2/ja not_active Expired - Fee Related
-
2010
- 2010-11-17 JP JP2010256651A patent/JP2011057693A/ja active Pending
- 2010-11-17 JP JP2010256652A patent/JP2011057694A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009298801A5 (ja) | ||
JP2013067643A5 (ja) | ||
PL410258A1 (pl) | Weterynaryjne doustne kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne, sposoby i zastosowania je obejmujące | |
BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
JP2016509067A5 (ja) | ||
BRPI1012066A2 (pt) | composição para o cuidado oral , e, métodos para preparar a composição para o cuidado oral e para administrar um composto de zinco a um indivíduo animal ou humano em necessidade do mesmo | |
BRPI1009860A2 (pt) | composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais | |
FR2935084B1 (fr) | Additif pour l'alimentation animale et son procede de preparation | |
BR112012003862A2 (pt) | sistema e método para monitoramento das características de alimentação de animais de pastagem em um pasto e método de gerenciamento de animais de pastagem em um pasto | |
JP2010529146A5 (ja) | ||
NO20091464L (no) | Heterocykliske forbindelser anvendelige som anaboliske midler for buskapsdyr | |
JP2015523346A5 (ja) | ||
WO2014052780A3 (en) | Compositions and methods of use of an inappetance-controlling compound | |
JP2009538344A5 (ja) | ||
BR112012005127A2 (pt) | composição anti-helmíntica na forma de um grânulo estável, sistema de dosagem para dosar oralmente animais com um agente anti-helmíntico e método para formar uma composição de anti-helmíntico. | |
FR2935870B1 (fr) | Additif bi-aromatise pour l'alimentation animale et son procede de preparation. | |
JP2012505178A5 (ja) | ||
EA201390392A1 (ru) | Способы подавления заражения насекомыми | |
JP2015513396A5 (ja) | ||
WO2012009542A3 (en) | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration | |
RU2011130121A (ru) | Способ лечения кокцидиоза (эймериоза) сельскохозяйственных животных и птиц | |
JP2012513411A5 (ja) | ||
FR2915874B3 (fr) | "dispositif d'insemination artificielle d'animaux d'elevage, notamment de truies" | |
UA108200C2 (uk) | Лікарські форми та способи застосування ектопаразитоцидів | |
RU2013150192A (ru) | Метапневмовирус птиц в онколизисе |